BOBBI CLARK: Open Payments
NPI 1922668904 · PINEHURST, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$913 in 40 payments from 23 companies in 2025. Trend: 2023 $447 · 2024 $935 · 2025 $913
Food & beverage: $913
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $124 |
| Merck Sharp & Dohme LLC | 4 | $120 |
| ABBVIE INC. | 4 | $70 |
| E.R. Squibb & Sons, L.L.C. | 3 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| Astellas Pharma US Inc | 2 | $44 |
| TerSera Therapeutics LLC | 2 | $40 |
| Gilead Sciences, Inc. | 2 | $37 |
| BeiGene USA, Inc. | 1 | $33 |
| Celgene Corporation | 2 | $32 |
Products named: KEYTRUDA, BRUKINSA, KISQALI, Nubeqa, Trodelvy, EMRELIS, OPDIVO, LUTATHERA.
Industry payments across NC — which companies pay providers there.
